Research News

Macrophage Signatures that Help Predict Lymphoma Patient’s Survival Rate

Macrophages are “big eaters” in our body; they are immune cells that engulf and kill invading organisms and cancer cells. Macrophages are present in the living ecosystem of many types of cancer. Using digital imaging, bioinformatics, and machine learning techniques, research led by N2CR member, Dr Anand Jeyasekharan, discovered 6 different macrophage signatures (MacroSigs) that can help distinguish types of macrophages in normal lymph nodes and diffuse large B-cell lymphoma (DLBCL), a tumour arising from our lymph nodes. This groundbreaking discovery helps doctors understand the evolution of this disease and how some DLBCL tumours relapse after chemotherapy. 

Read more: https://www.nature.com/articles/s41467-024-46220-z

Share this story:
Facebook
Twitter
LinkedIn

Related Research News

Research News

Next-Generation Sequencing in Metastatic Breast Cancer: A Game Changer for Asian Patients

This study, led by N2CR members Dr Joline Lim and A/Prof David Tan, looks at the use of next-generation sequencing …

Read More →
Research News

Mechanisms of sensitivity and resistance to CDK4/CDK6 inhibitors in hormone receptor-positive breast cancer treatment

Cell cycle dysregulation, a key feature of cancer, leads to excessive cell division. CDK4 and CDK6 are essential for cell …

Read More →
Research News

PHF2 regulates genome topology and DNA replication in neural stem cells via cohesion

When a cell divides to make new cells, it needs to copy its DNA so that each new cell has …

Read More →